Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads — coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

🧭 Guided View
New to markets — prices, yields, YTD, market cap? We explain every term as you browse, in plain English. Same data, with the help built in.

⚡ Expert View
You already know the market. Just the data — clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Security record · archived quarter

SLDB

Solid Biosciences Inc. · Healthcare · Biotechnology

9.80 -0.9% mkt cap $965.30M quote delayed (FMP) · as of Aug 26 18:08 UTC — separate from filing data below

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024
10Tracked holders
-1Δ holders
4.93MShares held
$19.74MReported value
+1New positions
−2Exits
Strongly Falling Conviction score 25/100 How these are computed → Explain this at the Research Desk →

Momentum inputs (comparable managers): holder breadth -9.1% · share flow -14.8% · net new positions -10.0%formula
Broad distribution — falling shares and fewer holders

All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024

Ownership over time
QuarterHoldersΔSharesReported valueNewExits
Q2 2026 72 +6 45.63M $455.47M +9 −3
Q1 2026 69 0 38.87M $279.42M +3 −3
Q4 2025 68 +2 30.07M $169.59M +2
Q3 2025 17 +1 23.96M $147.82M +1
Q2 2025 13 -1 26.02M $126.70M +1 −2
Q1 2025 11 +1 11.02M $40.79M +3 −2
Q4 2024 10 -1 4.93M $19.74M +1 −2
Q3 2024 10 +1 5.36M $37.37M +1
Q2 2024 9 5.20M $29.49M
Holder count
Who holds it · Q4 2024
#ManagerSharesΔ sharesValueTheir weightHeld
1 Adage Capital Partners 1.75M -0.3% $6.99M 0.0% ▼ Trim 3 SEC ↗
2 Citadel Advisors 948.42K +3.0% $3.79M 0.0% ▲ Add 3 SEC ↗
3 Citadel Advisors 948.42K +3.0% $3.79M 0.0% ▲ Add 3 SEC ↗
4 Millennium Management 719.78K -35.6% $2.88M 0.0% ▼ Trim 3 SEC ↗
5 Geode Capital Management (passive) 509.80K +1.0% $2.04M 0.0% ▲ Add 3 SEC ↗
6 Geode Capital Management (passive) 509.80K +1.0% $2.04M 0.0% ▲ Add 3 SEC ↗
7 State Street Global Advisors (passive) 432.18K $1.73M 0.0% n/c 1 SEC ↗
8 Marshall Wace 181.50K -3.1% $726,004 0.0% ▼ Trim 3 SEC ↗
9 Marshall Wace 181.50K -3.1% $726,004 0.0% ▼ Trim 3 SEC ↗
10 Two Sigma Investments 136.15K -32.9% $544,580 0.0% ▼ Trim 3 SEC ↗
11 Wellington Management 124.55K +4.0% $498,204 0.0% ▲ Add 3 SEC ↗
12 Wellington Management 124.55K +4.0% $498,204 0.0% ▲ Add 3 SEC ↗
13 Renaissance Technologies 82.49K +12.7% $329,972 0.0% ▲ Add 3 SEC ↗
14 D. E. Shaw & Co. 51.97K New $207,888 0.0% New 1 SEC ↗

“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.

New buyers

D. E. Shaw & Co. $207,888 0.0%

Exited

Point72 Asset Management $3.09M was 0.0%
AQR Capital Management $264,414 was 0.0%

Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 137 holders, 96.05M shares, $689.27M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.

Frequently co-owned

What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.

Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR. Reporting period: Q4 2024 · Methodology · Get this via the API